Literature DB >> 11600462

Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein.

P A Hall1, A C Woodman, S J Campbell, N A Shepherd.   

Abstract

BACKGROUND: While loss of p53 function is a key oncogenic step in human tumorigenesis, mutations of p53 are generally viewed as late events in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's oesophagus. Recent reports of a series of genes (p63, p73, and others) exhibiting close homology to p53 raise the possibility that abnormalities of these p53 family members may exert their influence earlier in the sequence. AIM: Following recent characterisation of expression of p63 and a major isoform DeltaNp63 by generation of an antiserum that recognises p63 isoforms, but not p53, our aim was a comparative study of expression of p63 protein and p53 protein in a morphologically well defined biopsy series representative of all stages of the metaplasia-dysplasia-carcinoma sequence in Barrett's oesophagus.
METHODS: A series of 60 biopsy cases representing normal oesophagus through to invasive adenocarcinoma were stained, using immunohistochemistry, with antibodies to p63 and p53. All biopsies derived from patients with endoscopic and histopathological substantiation of a diagnosis of traditional/classical Barrett's oesophagus.
RESULTS: There was exact concordance in p53 and p63 expression in more advanced forms of neoplasia, high grade dysplasia, and invasive adenocarcinoma, while p63, but not p53, was detected in the proliferative compartment of some non-neoplastic oesophageal tissue, in both squamous mucosa and in the non-neoplastic metaplastic glandular epithelium.
CONCLUSIONS: In neoplastic Barrett's oesophagus there is upregulation of both p63 and p53 while p63 isoforms may well have an important role in epithelial biology in both non-metaplastic and metaplastic mucosa of the oesophagus. While abnormalities of p53 function represent an indisputable and critical element of neoplastic transformation, other closely linked genes and their proteins have a role in both the physiology and pathophysiology of the oesophageal mucosa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600462      PMCID: PMC1728522          DOI: 10.1136/gut.49.5.618

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.

Authors:  A Zaika; N Marchenko; U M Moll
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

2.  17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.

Authors:  P L Blount; P C Galipeau; C A Sanchez; K Neshat; D S Levine; J Yin; H Suzuki; J M Abraham; S J Meltzer; B J Reid
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

Review 3.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

Authors:  S J Spechler; R K Goyal
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

4.  p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significance.

Authors:  J F Fléjou; F Paraf; F Potet; F Muzeau; F Fékété; D Hénin
Journal:  Histopathology       Date:  1994-05       Impact factor: 5.087

5.  Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.

Authors:  R H Hardwick; N A Shepherd; M Moorghen; P V Newcomb; D Alderson
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

6.  Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.

Authors:  K K Krishnadath; H W Tilanus; M van Blankenstein; F T Bosman; A H Mulder
Journal:  J Pathol       Date:  1995-02       Impact factor: 7.996

Review 7.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

8.  TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus.

Authors:  R Hamelin; J F Fléjou; F Muzeau; F Potet; P Laurent-Puig; F Fékété; G Thomas
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

9.  Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression.

Authors:  J P Molès; J T Schiller; A Tesniere; I M Leigh; J J Guilhou; N Basset-Séguin
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

10.  Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo.

Authors:  C A Midgley; B Owens; C V Briscoe; D B Thomas; D P Lane; P A Hall
Journal:  J Cell Sci       Date:  1995-05       Impact factor: 5.285

View more
  3 in total

Review 1.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

2.  Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.

Authors:  Yoshitsugu Mitani; Jie Li; Randal S Weber; Scott L Lippman; Elsa R Flores; Carlos Caulin; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

Review 3.  Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM.

Authors:  Ramon U Jin; Jason C Mills
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.